Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Rabin KR
  • MESH
  • Antineoplastic Agents
  • Female
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Remission Induction
  • Stem Cell Transplantation
  • Treatment Failure

Unbound MEDLINE

Attacking remaining challenges in childhood leukemia.

Links

  • Publisher Full Text
  • Authors

    Rabin KR

    Source

    The New England journal of medicine 366:15 2012 Apr 12 pg 1445-6

    MeSH

    Antineoplastic Agents
    Female
    Humans
    Male
    Precursor Cell Lymphoblastic Leukemia-Lymphoma
    Remission Induction
    Stem Cell Transplantation
    Treatment Failure

    Pub Type(s)

    Comment
    Editorial

    Language

    eng

    PubMed ID

    22494125

    Related Citations

    • Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now?
    • Imatinib for relapsed BCR/ABL positive leukemias.
    • Autologous bone-marrow transplantation in childhood acute lymphoblastic leukaemia.
    • Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.
    • Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.
    • Risk-adapted treatment of pediatric acute lymphoblastic leukemia.
    • Philadelphia chromosome-positive acute lymphoblastic leukemia in children.
    • The role of allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved